查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1716362

2032 年牙科麻醉劑市場預測：按麻醉劑類型、給藥途徑、應用、最終用戶和地區進行的全球分析

Dental Anesthetics Market Forecasts to 2032 - Global Analysis By Type of Anesthetic (Local Anesthetics, General Anesthetics and Sedatives), Route of Administration (Injectable and Topical), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球牙科麻醉劑市場預計在 2025 年達到 21 億美元，到 2032 年將達到 31 億美元，預測期內的複合年成長率為 5.7%。

牙科麻醉劑是麻木口腔某些區域的藥物，可減輕牙科治療期間的疼痛和不適。根據患者的需要和麻醉劑的強度，可以使用局部麻醉、局部麻醉劑全身麻醉劑。牙科麻醉劑常用於根管治療、填充和拔牙，它可以阻斷某些區域的神經訊號，使牙醫能夠安全舒適地進行手術，而不會給患者帶來疼痛或不適。

根據世界衛生組織（WHO）的數據，全球約有35億人患有口腔疾病，其中約20億人恆牙患有齲齒，5.14億兒童乳牙患有齲齒。

牙科疾病增加

齲齒和牙周病等牙科疾病的盛行率不斷上升，大大推動了牙科麻醉劑市場的發展。隨著口腔衛生知識的增加，越來越多的人接受牙科治療，包括補牙和拔牙等常規程序。這些手術需要有效的麻醉方法來確保患者的舒適。此外，年輕人牙科疾病的增加也推高了麻醉劑的需求。全球牙科護理的可近性和診斷技術的進步也極大地推動了市場的成長。

潛在的副作用和併發症

牙科麻醉劑行業由於可能產生的副作用以及應用相關的問題而面臨困難。對過敏反應、毒性和長時間麻木的擔憂可能會阻止患者選擇特定的麻醉劑。此外，不當的給藥可能會導致神經損傷和系統性問題，引起醫療保健提供者的擔憂。這些風險需要密切監測和專家管理，並限制某些麻醉劑的廣泛使用。此外，患者對麻醉相關不適的擔憂可能會阻礙市場擴張。

尖端麻醉劑和輸送系統的開發

由於麻醉劑配方和輸送技術的進步，預計將實現顯著成長。創新技術包括電腦控制局部麻醉輸送 (CCLAD) 設備，可提高注射精度並減輕疼痛。此外，對更耐用、更安全的配方的研究正在提高功效，同時最大限度地減少不良影響。這些進步是為了滿足人們對非侵入性牙科治療（尤其是美容和兒科護理）日益成長的需求。此外，製造商和醫療保健專業人員之間的夥伴關係正在推動客製化麻醉解決方案的創新，以滿足不同患者的需求。

嚴格的監管核准流程

牙科麻醉劑核准的嚴格監管程序阻礙了市場擴張。製造商必須遵守複雜的法令遵循，以確保其產品安全有效，有時會導致產品發布延遲或價格上漲。此外，地區法規的差異也阻礙了全球分銷計劃。這些障礙限制了較小營業單位的創新，因為它們可能缺乏進行全面臨床試驗和監管提交所需的資源。此外，加強對不利影響的審查會使核准過程變得更加困難。

COVID-19的影響：

由於封鎖期間牙科治療數量減少，COVID-19 疫情對牙科麻醉劑業務產生了不利影響。全球供應鏈問題影響了麻醉劑的供應。此外，由於患者出於健康考量而不願去診所，需要麻醉的常規手術也減少了。疫情後的復甦得益於人們對口腔健康的認知提高以及人口結構的變化增加了對牙科護理的需求。此外，遠距牙科和微創技術的進步預計將在整個預測期內推動市場擴張。

預計在預測期內局部麻醉劑市場將成長至最大的佔有率。

由於局部麻醉劑劑廣泛應用於填充和拔牙等常見的牙科手術中，預計在預測期內將佔據最大的市場佔有率。局部麻醉劑的優點是對全身的副作用較小，並且比全身麻醉更經濟。Lidocaine因其安全性和有效性仍然是局部麻醉的標準。此外，單齒麻醉裝置等技術創新提高了麻醉的精確度和病患在麻醉過程中的舒適度。無痛治療的需求日益成長，推動了市場成長，使局部麻醉劑成為現代牙科的重要組成部分。

預計門診手術中心 (ASC) 部分在預測期內將實現最高的複合年成長率。

在預測期內，門診手術中心 (ASC) 部分預計將呈現最高的成長率，因為與傳統醫院環境相比，它們能夠以更低的價格有效地提供門診手術。門診手術中心 (ASC) 正在滿足日益成長的微創手術需求，以滿足患者對便利性的偏好並提供更快的康復。此外，醫療技術的進步使得 ASC 能夠在麻醉下安全地進行複雜的手術。在許多國家，ASC 與醫療保健提供者之間的合作越來越受到認可，以最佳化營運並提高護理品質。

比最大的地區

在預測期內，由於人們對口腔健康的認知不斷提高以及對牙科保健基礎設施的大量投資，預計北美將佔據最大的市場佔有率。該地區受益於先進的診斷技術和日益成長的需要在麻醉下定期進行牙科手術的老年人口。此外，對美容牙科日益成長的需求也大大推動了市場的成長。推動創新的關鍵營業單位的參與確保透過策略夥伴關係和符合當地需求的產品推出實現持續成長。

複合年成長率最高的地區：

在預測期內，由於公眾口腔衛生意識的增強和都市化進程的加快，預計亞太地區將呈現最高的複合年成長率。在中國和印度等新興國家，可支配收入的增加使得人們能夠更享受現代牙科保健服務。此外，政府努力改善醫療保健基礎設施，使人們更方便地獲得需要麻醉的有效治療。該地區的中等收入階層正在擴大，對採用最新麻醉方法的美容牙科的需求也日益成長。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球牙科麻醉劑市場（依麻醉劑類型分類）

  • 局部麻醉劑
    • 醯胺類局部麻醉劑
      • Lidocaine
      • Articaine
      • Prilocaine
      • Bupivacaine
      • Mepivacaine
      • 其他醯胺類麻醉劑
    • 酯類局部麻醉劑
      • 普魯卡因
      • Benzocaine
      • 丁卡因
      • 其他酯類麻醉劑
  • 全身麻醉
    • 吸入全身麻醉劑
    • 靜脈全身麻醉
  • 鎮靜劑
    • 氧化亞氮
    • 口服鎮靜劑
    • 靜脈鎮靜

6. 全球牙科麻醉劑市場（依給藥途徑分類）

  • 注射
  • 局部的
    • 凝膠
    • 噴
    • 修補

7. 全球牙科麻醉劑市場（按應用）

  • 修復牙科
  • 牙周病學
  • 口腔外科
  • 義肢
  • 植入
  • 兒童牙科
  • 美容牙科
  • 其他用途

8. 全球牙科麻醉劑市場（依最終用戶）

  • 牙醫診所
  • 醫院
  • 門診手術中心（ASC）
  • 牙科研究所

9. 全球牙科麻醉劑市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Dentsply Sirona
  • Septodont
  • Pierrel SpA
  • Henry Schein Inc.
  • Hikma Pharmaceuticals PLC
  • 3M Company
  • Primex Pharmaceuticals
  • Aspen Group
  • Laboratorios Inibsa
  • Laboratorios Normon
  • Cetylite Inc.
  • Zeyco
  • Milestone Scientific
  • Centrix, Inc.
  • Crosstex International, Inc.
  • HANSAmed Limited
Product Code: SMRC29173

According to Stratistics MRC, the Global Dental Anesthetics Market is accounted for $2.1 billion in 2025 and is expected to reach $3.1 billion by 2032, growing at a CAGR of 5.7% during the forecast period. Dental anesthetics are drugs that reduce pain and suffering during dental treatments by numbing particular parts of the mouth. Depending on the patient's demands and the intensity of the surgery, they can be topical, local, or general anesthetics. Dental anesthetics, which are frequently used in root canals, fillings, and extractions, block nerve signals in specific regions, enabling dentists to treat patients securely, comfortably, and without causing them any pain or discomfort.

According to data from the World Health Organization, oral diseases affected approximately 3.5 billion people globally, with around 2 billion suffering from caries of permanent teeth and 514 million children affected by caries of primary teeth.

Market Dynamics:

Driver:

Increasing prevalence of dental diseases

The increasing incidence of dental illnesses, including caries and periodontal diseases, significantly propels the dental anesthetics market. As knowledge of oral health rises, more individuals are pursuing dental treatments, encompassing regular operations such as fillings and extractions. These procedures require efficient anesthetic methods to guarantee patient comfort. Furthermore, the increasing prevalence of dental problems in youngsters enhances the demand for anesthetics. Global accessibility to dental care and advancements in diagnostic technology also significantly boost market growth.

Restraint:

Potential side effects and complications

The dental anesthetics industry encounters difficulties stemming from possible adverse effects and issues linked to its application. Concerns such as allergic reactions, toxicity, and extended numbness may dissuade patients from selecting specific anesthetic agents. Moreover, inappropriate administration may result in nerve injury or systemic issues, heightening concerns among healthcare providers. These dangers require rigorous oversight and expert management, constraining the broad utilization of certain anesthetics. Furthermore, patient anxiety concerning anesthesia-related discomfort may hinder market expansion.

Opportunity:

Development of advanced anesthetic agents and delivery systems

Advancements in anesthetic formulations and delivery technologies provide substantial growth prospects. Innovations include computer-controlled local anesthesia delivery (CCLAD) devices that enhance precision and reduce pain during injections. Furthermore, investigations into more durable and safer formulations improve efficacy while minimizing unwanted effects. These advancements address the increasing demand for non-invasive dental treatments, especially in cosmetic dentistry and pediatric care. Moreover, partnerships between manufacturers and healthcare professionals foster innovation in anesthetic solutions customized for various patient requirements.

Threat:

Stringent regulatory approval processes

Strict regulatory procedures for the approval of dental anesthetics hinder market expansion. Manufacturers must traverse intricate compliance regulations to guarantee product safety and efficacy, sometimes delaying product launches and escalating prices. Furthermore, discrepancies in rules among regions hamper worldwide distribution plans. These obstacles constrain innovation among smaller entities that may lack the resources for comprehensive clinical trials and regulatory applications. Additionally, increased examination of negative impacts exacerbates the approval process.

Covid-19 Impact:

The Covid-19 outbreak adversely affected the dental anesthetics business because of a decline in dental treatments during lockdowns. Global supply chain issues impacted the availability of anesthetic drugs. Additionally, patients' reluctance to attend clinics due to health concerns led to a decrease in regular procedures requiring anesthetics. Post-pandemic recovery is due to increased awareness of oral health and demographic changes that increase the need for dental care. Moreover, throughout the forecast period, we expect advancements in teledentistry and minimally invasive techniques to enhance market expansion.

The local anesthetics segment is expected to be the largest during the forecast period

The local anesthetics segment is expected to account for the largest market share during the forecast period owing to their extensive application in common dental procedures, such as fillings and extractions. They provide benefits including fewer systemic adverse effects and economic efficiency relative to general anesthesia. Lidocaine continues to be the benchmark for local anesthesia, owing to its safety and efficacy. Furthermore, technological innovations such as single-tooth anesthetic devices improve accuracy and patient comfort during delivery. The rising need for painless treatments propels market growth, rendering local anesthetics essential in contemporary dentistry.

The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate owing to its efficacy in providing outpatient operations at reduced prices compared to conventional hospital environments. Ambulatory Surgical Centers (ASCs) address the increasing need for less invasive procedures that offer expedited recovery, in accordance with patient preferences for convenience. Furthermore, innovations in medical technology allow ASCs to conduct intricate surgeries securely under anesthesia. Collaborations between ASCs and healthcare providers optimize operations and improve care quality, thereby increasing their acceptance in many countries.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to heightened awareness of oral health and significant investments in dental care infrastructure. The area benefits from sophisticated diagnostic technology and an increasing elderly population necessitating regular dental procedures under anesthesia. Furthermore, the increasing demand for cosmetic dentistry substantially drives market growth. The involvement of pivotal entities fostering innovation guarantees continuous growth via strategic partnerships and product introductions customized to regional demands.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to heightened public awareness regarding oral health and rapid urbanization. Increasing disposable incomes facilitate access to modern dental care services in rising economies such as China and India. Moreover, governmental actions that advance healthcare infrastructure development improve access to effective treatments necessitating anesthesia. The expanding middle class in the region is increasing the need for cosmetic dentistry utilizing contemporary anesthetic methods.

Key players in the market

Some of the key players in Dental Anesthetics Market include Dentsply Sirona, Septodont, Pierrel S.p.A., Henry Schein Inc., Hikma Pharmaceuticals PLC, 3M Company, Primex Pharmaceuticals, Aspen Group, Laboratorios Inibsa, Laboratorios Normon, Cetylite Inc., Zeyco, Milestone Scientific, Centrix, Inc., Crosstex International, Inc., and HANSAmed Limited.

Key Developments:

In March 2025, Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, and Rapid Shape, a leading innovator in German-engineered dental 3D printing technology are pleased to announce a collaboration to validate the Lucitone Digital Print Denture workflow and material system on Rapid Shape's 3D printing solutions for digital denture manufacturing.

In May 2024, Laboratorios Inibsa Launched Prestoject(R) Dental Syringes for enhanced precision in administering anesthesia. Prestoject(R) Dental Syringes are meticulously designed to provide a solution that sets a new standard for comfortable and successful dental anaesthesia.

In August 2023, 3M announced it has completed the sale of certain assets from its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments. These local anesthetic products, sold primarily in Europe and Asia, include products sold under the Ubistesin(TM), Xylestesin(TM) and Mepivastesin(TM) brands as well as related syringe and needle products. These were formerly a part of the dental materials business in 3M's Oral Care Solutions Division.

Type of Anesthetics Covered:

  • Local Anesthetics
  • General Anesthetics
  • Sedative

Route of Administrations Covered:

  • Injectable
  • Topical

Applications Covered:

  • Restorative Dentistry
  • Periodontics
  • Oral Surgery
  • Prosthodontics
  • Implantology
  • Pediatric Dentistry
  • Cosmetic Dentistry
  • Other Applications

End Users Covered:

  • Dental Clinics
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Dental Research Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dental Anesthetics Market, By Type of Anesthetic

  • 5.1 Introduction
  • 5.2 Local Anesthetics
    • 5.2.1 Amide-based Local Anesthetics
      • 5.2.1.1 Lidocaine
      • 5.2.1.2 Articaine
      • 5.2.1.3 Prilocaine
      • 5.2.1.4 Bupivacaine
      • 5.2.1.5 Mepivacaine
      • 5.2.1.6 Other Amide-based Anesthetics
    • 5.2.2 Ester-based Local Anesthetics
      • 5.2.2.1 Procaine
      • 5.2.2.2 Benzocaine
      • 5.2.2.3 Tetracaine
      • 5.2.2.4 Other Ester-based Anesthetics
  • 5.3 General Anesthetics
    • 5.3.1 Inhalation General Anesthetics
    • 5.3.2 Intravenous General Anesthetics
  • 5.4 Sedative
    • 5.4.1 Nitrous Oxide
    • 5.4.2 Oral Sedatives
    • 5.4.3 Intravenous Sedatives

6 Global Dental Anesthetics Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Injectable
  • 6.3 Topical
    • 6.3.1 Gels
    • 6.3.2 Sprays
    • 6.3.3 Patches

7 Global Dental Anesthetics Market, By Application

  • 7.1 Introduction
  • 7.2 Restorative Dentistry
  • 7.3 Periodontics
  • 7.4 Oral Surgery
  • 7.5 Prosthodontics
  • 7.6 Implantology
  • 7.7 Pediatric Dentistry
  • 7.8 Cosmetic Dentistry
  • 7.9 Other Applications

8 Global Dental Anesthetics Market, By End User

  • 8.1 Introduction
  • 8.2 Dental Clinics
  • 8.3 Hospitals
  • 8.4 Ambulatory Surgical Centers (ASCs)
  • 8.5 Dental Research Institutes

9 Global Dental Anesthetics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Dentsply Sirona
  • 11.2 Septodont
  • 11.3 Pierrel S.p.A.
  • 11.4 Henry Schein Inc.
  • 11.5 Hikma Pharmaceuticals PLC
  • 11.6 3M Company
  • 11.7 Primex Pharmaceuticals
  • 11.8 Aspen Group
  • 11.9 Laboratorios Inibsa
  • 11.10 Laboratorios Normon
  • 11.11 Cetylite Inc.
  • 11.12 Zeyco
  • 11.13 Milestone Scientific
  • 11.14 Centrix, Inc.
  • 11.15 Crosstex International, Inc.
  • 11.16 HANSAmed Limited

List of Tables

  • Table 1 Global Dental Anesthetics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Dental Anesthetics Market Outlook, By Type of Anesthetic (2024-2032) ($MN)
  • Table 3 Global Dental Anesthetics Market Outlook, By Local Anesthetics (2024-2032) ($MN)
  • Table 4 Global Dental Anesthetics Market Outlook, By Amide-based Local Anesthetics (2024-2032) ($MN)
  • Table 5 Global Dental Anesthetics Market Outlook, By Lidocaine (2024-2032) ($MN)
  • Table 6 Global Dental Anesthetics Market Outlook, By Articaine (2024-2032) ($MN)
  • Table 7 Global Dental Anesthetics Market Outlook, By Prilocaine (2024-2032) ($MN)
  • Table 8 Global Dental Anesthetics Market Outlook, By Bupivacaine (2024-2032) ($MN)
  • Table 9 Global Dental Anesthetics Market Outlook, By Mepivacaine (2024-2032) ($MN)
  • Table 10 Global Dental Anesthetics Market Outlook, By Other Amide-based Anesthetics (2024-2032) ($MN)
  • Table 11 Global Dental Anesthetics Market Outlook, By Ester-based Local Anesthetics (2024-2032) ($MN)
  • Table 12 Global Dental Anesthetics Market Outlook, By Procaine (2024-2032) ($MN)
  • Table 13 Global Dental Anesthetics Market Outlook, By Benzocaine (2024-2032) ($MN)
  • Table 14 Global Dental Anesthetics Market Outlook, By Tetracaine (2024-2032) ($MN)
  • Table 15 Global Dental Anesthetics Market Outlook, By Other Ester-based Anesthetics (2024-2032) ($MN)
  • Table 16 Global Dental Anesthetics Market Outlook, By General Anesthetics (2024-2032) ($MN)
  • Table 17 Global Dental Anesthetics Market Outlook, By Inhalation General Anesthetics (2024-2032) ($MN)
  • Table 18 Global Dental Anesthetics Market Outlook, By Intravenous General Anesthetics (2024-2032) ($MN)
  • Table 19 Global Dental Anesthetics Market Outlook, By Sedative (2024-2032) ($MN)
  • Table 20 Global Dental Anesthetics Market Outlook, By Nitrous Oxide (2024-2032) ($MN)
  • Table 21 Global Dental Anesthetics Market Outlook, By Oral Sedatives (2024-2032) ($MN)
  • Table 22 Global Dental Anesthetics Market Outlook, By Intravenous Sedatives (2024-2032) ($MN)
  • Table 23 Global Dental Anesthetics Market Outlook, By Route of Administration (2024-2032) ($MN)
  • Table 24 Global Dental Anesthetics Market Outlook, By Injectable (2024-2032) ($MN)
  • Table 25 Global Dental Anesthetics Market Outlook, By Topical (2024-2032) ($MN)
  • Table 26 Global Dental Anesthetics Market Outlook, By Gels (2024-2032) ($MN)
  • Table 27 Global Dental Anesthetics Market Outlook, By Sprays (2024-2032) ($MN)
  • Table 28 Global Dental Anesthetics Market Outlook, By Patches (2024-2032) ($MN)
  • Table 29 Global Dental Anesthetics Market Outlook, By Application (2024-2032) ($MN)
  • Table 30 Global Dental Anesthetics Market Outlook, By Restorative Dentistry (2024-2032) ($MN)
  • Table 31 Global Dental Anesthetics Market Outlook, By Periodontics (2024-2032) ($MN)
  • Table 32 Global Dental Anesthetics Market Outlook, By Oral Surgery (2024-2032) ($MN)
  • Table 33 Global Dental Anesthetics Market Outlook, By Prosthodontics (2024-2032) ($MN)
  • Table 34 Global Dental Anesthetics Market Outlook, By Implantology (2024-2032) ($MN)
  • Table 35 Global Dental Anesthetics Market Outlook, By Pediatric Dentistry (2024-2032) ($MN)
  • Table 36 Global Dental Anesthetics Market Outlook, By Cosmetic Dentistry (2024-2032) ($MN)
  • Table 37 Global Dental Anesthetics Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 38 Global Dental Anesthetics Market Outlook, By End User (2024-2032) ($MN)
  • Table 39 Global Dental Anesthetics Market Outlook, By Dental Clinics (2024-2032) ($MN)
  • Table 40 Global Dental Anesthetics Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 41 Global Dental Anesthetics Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 42 Global Dental Anesthetics Market Outlook, By Dental Research Institutes (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.